ANIX
Income statement / Annual
Last year (2023), Anixa Biosciences, Inc.'s total revenue was $210,000.00,
a decrease of 99.99% from the previous year.
In 2023, Anixa Biosciences, Inc.'s net income was -$9.81 M.
See Anixa Biosciences, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
10/31/2023 |
10/31/2022 |
10/31/2021 |
10/31/2020 |
10/31/2019 |
10/31/2018 |
10/31/2017 |
10/31/2016 |
10/31/2015 |
10/31/2014 |
| Operating Revenue |
$210,000.00
|
$2.47 B
|
$512,500.00
|
$0.00
|
$250,000.00
|
$1.11 M
|
$362,500.00
|
$300,000.00
|
$9.26 M
|
$3.67 M
|
| Cost of Revenue |
$161,000.00 |
$42,000.00 |
$385,002.00 |
$90,157.00 |
$166,250.00 |
$768,410.00 |
$104,556.00 |
$217,416.00 |
$3.65 M |
$1.99 M |
| Gross Profit |
$49,000.00 |
$2.47 B |
$127,498.00 |
-$90,157.00 |
$83,750.00 |
$344,090.00 |
$257,944.00 |
$82,584.00 |
$5.61 M |
$1.68 M |
| Gross Profit Ratio |
0.23 |
1 |
0.25 |
0 |
0.34 |
0.31 |
0.71 |
0.28 |
0.61 |
0.46 |
| Research and Development
Expenses |
$4.77 M
|
$6.70 M
|
$6.19 M
|
$4.38 M
|
$5.47 M
|
$6.81 M
|
$1.60 M
|
$1.56 M
|
$711,391.00
|
$1.19 M
|
| General & Administrative
Expenses |
$6.29 M
|
$7.17 M
|
$7.07 M
|
$5.60 M
|
$5.66 M
|
$6.91 M
|
$4.41 M
|
$2.71 M
|
$5.51 M
|
$6.41 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.29 M
|
$7.17 M
|
$7.07 M
|
$5.60 M
|
$5.66 M
|
$6.91 M
|
$4.41 M
|
$2.71 M
|
$5.51 M
|
$6.41 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$418,750.00 |
$0.00 |
-$13,100.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$11.06 M |
$13.88 M |
$13.26 M |
$9.98 M |
$11.56 M |
$14.05 M |
$6.33 M |
$4.59 M |
$6.55 M |
$6.72 M |
| Cost And Expenses |
$11.22 M |
$13.88 M |
$13.65 M |
$9.98 M |
$11.72 M |
$14.82 M |
$6.44 M |
$4.81 M |
$10.20 M |
$8.71 M |
| Interest Income |
$1.08 M |
$104,000.00 |
$2,322.00 |
$33,923.00 |
$71,353.00 |
$45,974.00 |
$19,440.00 |
$12,530.00 |
$17,622.00 |
$8,595.00 |
| Interest Expense |
$0.00 |
$104,000.00 |
$322.00 |
$0.00 |
$0.00 |
$0.00 |
$500,455.00 |
$519,946.00 |
$451,906.00 |
$1.26 M |
| Depreciation &
Amortization |
$46,000.00
|
$42,000.00
|
$59,864.00
|
$90,157.00
|
$466,308.00
|
$343,731.00
|
$368,512.00
|
$358,629.00
|
$337,806.00
|
$314,453.00
|
| EBITDA |
-$10.97 M
|
-$13.73 M
|
-$13.08 M
|
-$10.00 M
|
-$11.00 M
|
-$13.36 M
|
-$4.14 M
|
-$4.14 M
|
-$601,846.00
|
-$8.03 M
|
| EBITDA Ratio |
-52.21 |
-0.01 |
-25.52 |
0 |
-42.34 |
-11.49 |
-15.69 |
-13.79 |
-0.06 |
-1.29 |
| Operating Income Ratio
|
-52.43
|
-0.01
|
-25.63
|
0
|
-45.89
|
-12.84
|
-16.76
|
-15.03
|
-0.1
|
-1.38
|
| Total Other
Income/Expenses Net |
$1.08 M
|
$104,000.00
|
$7,692.00
|
-$114,161.00
|
$71,353.00
|
$45,974.00
|
$1.07 M
|
-$507,416.00
|
-$434,284.00
|
-$4.56 M
|
| Income Before Tax |
-$9.93 M |
-$13.77 M |
-$13.13 M |
-$10.09 M |
-$11.82 M |
-$14.24 M |
-$5.01 M |
-$5.02 M |
-$1.38 M |
-$9.61 M |
| Income Before Tax Ratio
|
-47.29
|
-0.01
|
-25.62
|
0
|
-47.27
|
-12.8
|
-13.82
|
-16.72
|
-0.15
|
-2.62
|
| Income Tax Expense |
$0.00 |
-$280,000.00 |
-$181,292.00 |
$40,153.00 |
$175,799.00 |
$289,946.00 |
$500,455.00 |
$12,530.00 |
$17,622.00 |
$1.26 M |
| Net Income |
-$9.81 M |
-$13.49 M |
-$12.95 M |
-$10.13 M |
-$11.99 M |
-$14.00 M |
-$5.01 M |
-$5.02 M |
-$1.38 M |
-$9.61 M |
| Net Income Ratio |
-46.72 |
-0.01 |
-25.26 |
0 |
-47.98 |
-12.58 |
-13.82 |
-16.72 |
-0.15 |
-2.62 |
| EPS |
-0.32 |
-0.44 |
-0.45 |
-0.46 |
-0.61 |
-0.79 |
-0.41 |
-0.57 |
-0.14 |
-1 |
| EPS Diluted |
-0.32 |
-0.44 |
-0.45 |
-0.46 |
-0.61 |
-0.79 |
-0.41 |
-0.57 |
-0.14 |
-1 |
| Weighted Average Shares
Out |
$30.98 M
|
$30.37 M
|
$28.58 M
|
$22.23 M
|
$19.79 M
|
$17.62 M
|
$12.20 M
|
$8.74 M
|
$9.63 M
|
$9.57 M
|
| Weighted Average Shares
Out Diluted |
$30.98 M
|
$30.37 M
|
$28.58 M
|
$22.23 M
|
$19.79 M
|
$17.62 M
|
$12.20 M
|
$8.74 M
|
$9.63 M
|
$9.57 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
